Loading...
EP300 mutation is associated with tumor mutation burden and promotes antitumor immunity in bladder cancer patients
Bladder cancer is a leading cause of morbidity and mortality worldwide. Currently, immunotherapy has become a worthwhile therapy for bladder cancer. Tumor mutation burden (TMB) has been regarded as the most prevalent biomarker to predict immunotherapy. Bladder cancer is reported to have the third hi...
Na minha lista:
| Udgivet i: | Aging (Albany NY) |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Impact Journals
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7041765/ https://ncbi.nlm.nih.gov/pubmed/32012118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/aging.102728 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|